4-{3-[4-cyano-3-(trifluoroMethyl)phenyl]-5,5-diMethyl-4-oxo-2-sulfanylideneiMidazolidin-1-yl}-2-fluoro-N-MethylbenzaMide
|
EnzalutaMide
|
MDV3100 (EnzalutaMide)
|
ENZALUTAMIDE;MDV-3100
|
MDV-3100
|
4-[3-[4-Cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl]-2-fluoro-N-methylbenzamide
|
4-(3-(4-Cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl)-2-fluoro-N-methylbenzamide
|
MDV 3100,4-[3-[4-Cyano-3-(trifluoroMethyl)phenyl]-5,5-diMethyl-4-oxo-2-thioxo-1-iMidazolidinyl]-2-fluoro-N-MethylbenzaMide
|
4-(3-(4-Cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl)-2-fluoro-N
|
BenzaMide,4-[3-[4-cyano-3-(trifluoroMethyl)phenyl]-5,5-diMethyl-4-oxo-2-thioxo-1-iMidazolidinyl]-2-fluoro-N-Methyl-
|
4-[3-(4-Ethynyl-3-trifluoromethyl-phenyl)-5,5-dimethyl-4-oxo-2-thioxo-imidazolidin-1-yl]-2-fluoro-N-methyl-benzamide
|
4-[3-[4-Cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl]-2-fluoro-N-methylbenzamide MDV 3100
|
MDV3100,Menzalutamide
|
Xtandi (enzalutamide) (androgen receptor inhibitor)
|
4-Thiazolecarboxylic acid, 2-[(2,4,5-trimethoxybenzoyl)amino]-ethyl ester
|
Enzalutamide, >=99%
|
4-(3-(4-Cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl)-2-fluor
|
brand name: Xtandi.
|
MDV-3100; MDV 3100. ENZALUTAMIDE; BRAND NAME: XTANDI.
|
CS-355
|
4-{3-[4-CYANO-3-(TRIFLUOROMETHYL)PHENYL]-5,5-DIMETHYL-4-OXO-2-SULFANYLIDENEIMIDAZOLIDIN-1-YL}-2-FLUO
|
101095
|
Enzalutamide (Xtandi)
|
MDV 3100 fandachem
|
Ezalutamide
|
Enzalutamide (MDV3100) fandachem
|
5-dimethyl-4-oxo-2-thioxoimid azolidin-1-yl)-2-fluoro-Nmethylbenzamide
|
4-(3-(4-cyano-3-(trifluoromethyl)phenyl)-5
|
ENZALUTAMIDE 915087-33-1 MDV3100
|
4-(3-(4-Cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl)-2-fluoro-N(For export only)
|
Enzalutamide USP/EP/BP
|
4-Isothiocyanato-2-trifluoromethylbenzonitrile, 4-Isothiocyanato-2-(trifluoromethyl)benzonitril
|